safety of glp-1 receptor agonists Potential Use and GIP/GLP-1 for Respiratory Disorders: Where Are We at? Mapping the effectiveness and risks
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are transforming the way we approach weight loss
Montrose-Rafizadeh C, Avdonin P, Garant MJ, Rodgers BD, Kole S, Yang H, Levine MA, Schwindinger W, and Bernier M
Effect of subcutaneous semaglutide vs
As healthcare systems prioritize chronic disease management, GLP-1 receptor agonists are positioned to remain a critical component of treatment protocols
